Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - mepivacaine hydrochloride 20 mg/ml - solution for injection - 20 mg/ml - mepivacaine hydrochloride 20 mg/ml - mepivacaine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - mepivacaine hydrochloride 20 mg/ml - solution for injection - 20 mg/ml - mepivacaine hydrochloride 20 mg/ml - mepivacaine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - mepivacaine hydrochloride 20 mg/ml - solution for injection - 20 mg/ml - mepivacaine hydrochloride 20 mg/ml - mepivacaine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - mepivacaine hydrochloride 10 mg/ml - solution for injection - 10 mg/ml - mepivacaine hydrochloride 10 mg/ml - mepivacaine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - mepivacaine hydrochloride 20 mg/ml - solution for injection - 20 mg/ml - mepivacaine hydrochloride 20 mg/ml - mepivacaine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - mepivacaine hydrochloride - parenteral liquid/solution/suspension - mepivacaine hydrochloride caine active 20.0 mg/ml - anaesthetics/analgesics - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - anaesthetic - local/general | general anaesthetic | immobiliser | local anaesthetic | premedication | sedative | tranquilliser | travel sickness

Australia - English - Department of Health (Therapeutic Goods Administration)

specialites septodont pty ltd - mepivacaine hydrochloride, quantity: 30 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - indications as at may 2003: ato mepivacaine 3% is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

United States - English - NLM (National Library of Medicine)

septodont inc. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - bupivacaine hydrochloride 5 mg in 1 ml - vivacaine™ (bupivacaine hydrochloride and epinephrine injection, usp) is indicated for the production of local anesthesia for dental procedures by infiltration injection or nerve block in adults. vivacaine™ (bupivacaine hydrochloride and epinephrine injection, usp) is not recommended for children. vivacaine™ (bupivacaine hydrochloride and epinephrine injection, usp) is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide type or to other components of vivacaine™ (bupivacaine hydrochloride and epinephrine injection, usp) solutions.

United States - English - NLM (National Library of Medicine)

safco dental supply co. - articaine hydrochloride (unii: qs9014q792) (articaine - unii:d3sq406g9x), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - articaine hydrochloride 40 mg in 1 ml - articaine hcl and epinephrine is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures in adults and pediatric patients 4 years of age and older. articaine hcl and epinephrine is contraindicated in patients who are hypersensitive to products containing sulfites. products containing sulfites may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. sulfite sensitivity is seen more frequently in asthmatic than in non-asthmatic people [see warnings and precautions (5.5)] . teratogenic effects-pregnancy category c. there are no adequate and well-controlled studies in pregnant women with articaine with epinephrine. articaine hydrochloride and epinephrine (1:100,000) has been shown to increase fetal deaths and skeletal variations in rabbits when given in doses approximately 4 times the maximum recommended human dose (mrhd). articaine hcl and epinephrine should be used dur

United States - English - NLM (National Library of Medicine)

pierrel s.p.a. - articaine hydrochloride (unii: qs9014q792) (articaine - unii:d3sq406g9x), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - articaine hydrochloride 40 mg in 1 ml - orabloc is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures in adults and pediatric patients 4 years of age and older. orabloc is contraindicated in patients who are hypersensitive to products containing sulfites. products containing sulfites may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. sulfite sensitivity is seen more frequently in asthmatic than in non-asthmatic people [see warnings and precautions (5.5)] . teratogenic effects-pregnancy category c. there are no adequate and well-controlled studies in pregnant women with articaine with epinephrine. articaine hydrochloride and epinephrine (1:100,000) has been shown to increase fetal deaths and skeletal variations in rabbits when given in doses approximately 4 times the maximum recommended human dose (mrhd). orabloc should be used during pregnancy only if the potential benefit justifies the potentia